Niels Krejci, MD
MOHS-Micrographic Surgery · Norwood, MANPI 1518958289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 35.4% of the total.
Across 162 payments — averaging $23.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sanofi$243
- Novartis$212
- Incyte Corporation$209
- E.r. Squibb & Sons, L.L.C.$208
- Amgen$199
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,804100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $1,345 |
| Sanofi | 9 | $243 |
| Novartis | 10 | $212 |
| Incyte Corporation | 8 | $209 |
| E.r. Squibb & Sons, L.L.C. | 9 | $208 |
| Amgen | 6 | $199 |
| Sun Pharmaceutical Industries Inc. | 10 | $193 |
| UCB, Inc. | 8 | $175 |
| LEO Pharma Inc. | 7 | $174 |
| Pfizer | 7 | $161 |
| Johnson & Johnson | 6 | $145 |
| Bristol Myers Squibb | 5 | $102 |
| Lilly USA, LLC | 3 | $76 |
| Almirall LLC | 4 | $73 |
| Dermira, Inc. | 2 | $54 |
| Boehringer Ingelheim | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| DUSA Pharmaceuticals, Inc. | 2 | $37 |
| Organon | 1 | $33 |
| Galderma Laboratories, L.p. | 2 | $29 |
| Biofrontera Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$3,804 in reported general payments places this provider in the 75th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 191 | $1,501 |
| Doxycycline Hyclate | 40 | $233 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Norwood
- Jennifer LeeNorwood$3K
- Chrysalyne SchmultsJamaica Plain$58K
- Suzanne OlbrichtBurlington$12K
- Sameer GuptaBoston$11K
- Thomas RohrerChestnut Hill$9K
- Helen RaynhamNatick$7K
- Omar BadriBeverly$7K
- Benjamin SolkyBoston$7K
- Carin LitaniWellesley Hills$5K
- Christine KannlerBeverly$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.